Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Dis Model Mech ; 7(7): 871-82, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24973754

ABSTRACT

Zebrafish embryos and larvae are now well-established models in which to study infectious diseases. Infections with non-pathogenic Gram-negative Escherichia coli induce a strong and reproducible inflammatory response. Here, we study the cellular response of zebrafish larvae when E. coli bacteria are injected into the notochord and describe the effects. First, we provide direct evidence that the notochord is a unique organ that is inaccessible to leukocytes (macrophages and neutrophils) during the early stages of inflammation. Second, we show that notochord infection induces a host response that is characterised by rapid clearance of the bacteria, strong leukocyte recruitment around the notochord and prolonged inflammation that lasts several days after bacteria clearance. During this inflammatory response, il1b is first expressed in macrophages and subsequently at high levels in neutrophils. Moreover, knock down of il1b alters the recruitment of neutrophils to the notochord, demonstrating the important role of this cytokine in the maintenance of inflammation in the notochord. Eventually, infection of the notochord induces severe defects of the notochord that correlate with neutrophil degranulation occurring around this tissue. This is the first in vivo evidence that neutrophils can degranulate in the absence of a direct encounter with a pathogen. Persistent inflammation, neutrophil infiltration and restructuring of the extracellular matrix are defects that resemble those seen in bone infection and in some chondropathies. As the notochord is a transient embryonic structure that is closely related to cartilage and bone and that contributes to vertebral column formation, we propose infection of the notochord in zebrafish larvae as a new model to study the cellular and molecular mechanisms underlying cartilage and bone inflammation.


Subject(s)
Escherichia coli Infections/embryology , Escherichia coli/physiology , Inflammation/pathology , Notochord/microbiology , Notochord/pathology , Zebrafish/embryology , Zebrafish/microbiology , Animals , Chronic Disease , Embryo, Nonmammalian/microbiology , Embryo, Nonmammalian/pathology , Escherichia coli/ultrastructure , Escherichia coli Infections/microbiology , Escherichia coli Infections/pathology , Green Fluorescent Proteins/metabolism , Inflammation/microbiology , Interleukin-1beta/metabolism , Larva/microbiology , Larva/ultrastructure , Macrophages/pathology , Neutrophil Infiltration , Neutrophils/pathology , Notochord/ultrastructure , Phagocytosis , Spine/embryology , Spine/pathology
2.
Foodborne Pathog Dis ; 9(11): 1028-36, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23009170

ABSTRACT

Non-O157 Shiga toxin-producing Escherichia coli (STEC) are emerging pathogens with the potential to cause serious illness and impact public health due to diagnostic challenges. Between 2005 and 2010, the Wadsworth Center (WC), the public health laboratory of the New York State (NYS) Department of Health, requested that Shiga toxin enzyme immunoassay (EIA)-positive stool enrichment broths and/or stool specimens be submitted by clinical and commercial reference laboratories testing NYS patient specimens. A total of 798 EIA-positive specimens were received for confirmation and serotyping, and additionally a subset of STEC was assessed for the presence of six virulence genes (stx1, stx2, eaeA, hlyA, nleA, and nleB) by real-time polymerase chain reaction. We confirmed 591 specimens as STEC, 164 (28%) as O157 STEC, and 427 (72%) as non-O157 STEC. Of the non-O157 STEC serogroups identified, over 70% were O103, O26, O111, O45, O121, or O145. During this time period, WC identified and characterized a total of 1282 STEC received as E. coli isolates, stool specimens, or EIA broths. Overall, the STEC testing identified 59% as O157 STEC and 41% as non-O157 STEC; however, out of 600 isolates submitted to the WC as E. coli cultures, 543 (90%) were identified as O157 STEC. This report summarizes a 6-year study utilizing enhanced STEC testing that resulted in increased identification and characterization of non-O157 STEC in NYS. Continued utilization of enhanced STEC testing may lead to effective and timely outbreak response and improve monitoring of trends in STEC disease epidemiology.


Subject(s)
Escherichia coli Infections/microbiology , Escherichia coli Proteins/genetics , Shiga Toxin/genetics , Shiga-Toxigenic Escherichia coli/isolation & purification , Algorithms , DNA, Bacterial/genetics , Escherichia coli Infections/embryology , Feces/microbiology , Humans , Immunoenzyme Techniques , New York/epidemiology , Public Health , Real-Time Polymerase Chain Reaction , Retrospective Studies , Serotyping , Shiga-Toxigenic Escherichia coli/classification , Shiga-Toxigenic Escherichia coli/genetics , Shiga-Toxigenic Escherichia coli/immunology , Virulence Factors/genetics
3.
J Matern Fetal Neonatal Med ; 24(2): 213-22, 2011 Feb.
Article in English | MEDLINE | ID: mdl-20476872

ABSTRACT

OBJECTIVE: In order to investigate the early gestational inflammation effect on the prenatal and postnatal lung development, identification of the proinflammatory cytokines (IL-1ß and TNF-α), genes implicated in angiogenesis (Vascular endothelial growth factor [VEGF], fms-like tyrosine kinase-1 [Flt-1], fetal liver kinase-1 [Flk-1]), and surfactant proteins (SPs) were observed. METHODS: Escherichia coli (E. coli) was inoculated into uterine cervix of pregnant rats at embryonic day 15 (E15) during pseudoglandular period of lung development and the control group was inoculated with normal saline. IL-1ß, TNF-α, VEGF, Flt-1, Flk-1, SP-A, and SP-B mRNA in pup's lung at E17, 19, 21 and postnatal day (P) 1, 3, 7, 14 were quantified by real-time RT-PCR. Western blot or immunohistochemistry analysis was also performed for the evaluation of VEGF, Flk-1, Flt-1, and SP-A expression in pup's lung. RESULTS: Compared with the control group, the fetal lung of the E. coli-treated group was more immature, the postnatal lung development was impaired marked by less alveoli, fewer secondary septa, and thicker alveolar wall. The lung weight and lung/body weight ratio were lower in the E. coli-treated group pups. IL-1ß and TNF-α mRNA were increased significantly in E. coli-treated pup's lung after birth, but no significant difference of IL-1ß and TNF-α mRNA levels in fetal lung were found between the two groups. SP-A expression was depressed at E17, E19, and E21 after intrauterine E. coli treated, accompanied with lower SP-B mRNA level at E19 and E21. Furthermore, intrauterine E. coli treated reduced the VEGF mRNA and protein levels in the fetal lung at E17 and E19, while the expression of Flt-1 and Flk-1 were higher at P7, P14 and P1, P7, P14, respectively, compared to the controls. CONCLUSIONS: These results suggested early gestational intrauterine E. coli infection could induce a postnatal pulmonary inflammation and might arrest the alveolarization in developing lung which was involved with the VEGF signaling. However, intrauterine E. coli infection could not induce the increase of proinflammatory cytokines in fetal lung and might fail to accelerate the maturation of fetal lung.


Subject(s)
Lung/growth & development , Pneumonia/etiology , Pregnancy Complications, Infectious/pathology , Prenatal Exposure Delayed Effects/etiology , Uterine Diseases/complications , Uterine Diseases/pathology , Animals , Animals, Newborn , Disease Models, Animal , Escherichia coli Infections/complications , Escherichia coli Infections/embryology , Female , Fetus/embryology , Fetus/pathology , Gestational Age , Lung/embryology , Lung/physiology , Lung Diseases/congenital , Lung Diseases/embryology , Lung Diseases/etiology , Pneumonia/congenital , Pneumonia/embryology , Pregnancy , Pregnancy Complications, Infectious/immunology , Pregnancy Complications, Infectious/physiopathology , Prenatal Exposure Delayed Effects/immunology , Prenatal Exposure Delayed Effects/pathology , Prenatal Exposure Delayed Effects/physiopathology , Rats , Rats, Sprague-Dawley , Uterine Diseases/embryology , Uterine Diseases/immunology
4.
Acta Paediatr ; 92(1): 81-6, 2003.
Article in English | MEDLINE | ID: mdl-12650305

ABSTRACT

AIM: To evaluate the effects of maternal antibiotic treatment on fetal brain cell death in a rabbit intrauterine infection model. METHODS: After Escherichia coli uterine-horn inoculation in 22 pregnant rabbits, followed at various times by ceftriaxone and caesarean section, cell death in white matter (histology and fragmented DNA staining) from fetuses killed at extraction was compared across groups using the Mantel-Haenszel test and Fisher's exact test for small numbers. RESULTS: White matter cell death was consistently present at 48 h, with ceftriaxone initiation at 24 h (group 1), detectable at 84 but not 60 h, with ceftriaxone initiation at 12 h, and significantly reduced at 84 h with ceftriaxone initiation at 6 h (60% vs 100% in group 1, p < 0.001, Fisher's exact test). CONCLUSION: Early maternal antibiotic therapy delays white matter cell death in rabbit fetuses exposed to intrauterine infection. This may provide a window for preventing white matter damage.


Subject(s)
Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Brain/drug effects , Brain/embryology , Ceftriaxone/pharmacology , Ceftriaxone/therapeutic use , Cerebral Ventricles , Escherichia coli Infections/drug therapy , Escherichia coli Infections/embryology , Animals , Anti-Bacterial Agents/administration & dosage , Brain/pathology , Ceftriaxone/administration & dosage , Cell Death/drug effects , Cell Death/physiology , Cerebral Ventricles/drug effects , Cerebral Ventricles/embryology , Cerebral Ventricles/pathology , Female , In Situ Nick-End Labeling , Injections, Intravenous , Pregnancy , Rabbits
SELECTION OF CITATIONS
SEARCH DETAIL
...